Author:
Rabey Jose Martin,Yarden Jennifer,Dotan Nir,Mechlovich Danit,Riederer Peter,Youdim Moussa B. H.
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference41 articles.
1. Ahlskog E (2000) Approach to the patient with a movement disorder: basic principles of neurologic diagnosis. From Parkinson’s disease and movement disorders : diagnosis and treatment guidelines for the practicing physician (edited by Adler CH and Ahlskog JE). Humana Press, Totowa, New Jersey, pp 3–34
2. Anderson DW, Schray RC, Duester G, Schneider JS (2011) Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system. Brain Res 1408:81–87
3. Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Teb S, Foltynie T (2017) Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet 390:1664–1675
4. Becerra JE, Zorro O, Ruiz-Gaviria R, Castañeda-Cardona C, Otálora-Esteban M, Henao S, Navarrete S, Acevedo JC, Rosselli D (2016) Economic analysis of deep brain stimulation in Parkinson disease: systematic review of the literature. World Neurosurg 93:44–49
5. Birkmayer W, Riederer P, Youdim MBH (1979) Distinction between benign and malignant type of Parkinson’s disease. Clin Neurol Neurosurg 81:158–164
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献